INBX
Price
$32.68
Change
+$0.84 (+2.64%)
Updated
Sep 26 closing price
Capitalization
473.38M
47 days until earnings call
IPSC
Price
$0.51
Change
+$0.02 (+4.08%)
Updated
Sep 26 closing price
Capitalization
43.98M
40 days until earnings call
Interact to see
Advertisement

INBX vs IPSC

Header iconINBX vs IPSC Comparison
Open Charts INBX vs IPSCBanner chart's image
Inhibrx Biosciences
Price$32.68
Change+$0.84 (+2.64%)
Volume$171.74K
Capitalization473.38M
Century Therapeutics
Price$0.51
Change+$0.02 (+4.08%)
Volume$534.46K
Capitalization43.98M
INBX vs IPSC Comparison Chart in %
Loading...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INBX vs. IPSC commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a StrongBuy and IPSC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (INBX: $32.68 vs. IPSC: $0.51)
Brand notoriety: INBX and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INBX: 148% vs. IPSC: 75%
Market capitalization -- INBX: $473.38M vs. IPSC: $43.98M
INBX [@Biotechnology] is valued at $473.38M. IPSC’s [@Biotechnology] market capitalization is $43.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 1 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • INBX’s FA Score: 1 green, 4 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, INBX is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 4 TA indicator(s) are bullish while IPSC’s TA Score has 5 bullish TA indicator(s).

  • INBX’s TA Score: 4 bullish, 4 bearish.
  • IPSC’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than INBX.

Price Growth

INBX (@Biotechnology) experienced а +18.41% price change this week, while IPSC (@Biotechnology) price change was +6.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

INBX is expected to report earnings on Nov 13, 2025.

IPSC is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($473M) has a higher market cap than IPSC($44M). INBX YTD gains are higher at: 112.208 vs. IPSC (-49.594). IPSC has higher annual earnings (EBITDA): -6.16M vs. INBX (-155.08M). INBX has more cash in the bank: 187M vs. IPSC (156M). IPSC has less debt than INBX: IPSC (51.5M) vs INBX (107M). IPSC has higher revenues than INBX: IPSC (114M) vs INBX (1.4M).
INBXIPSCINBX / IPSC
Capitalization473M44M1,075%
EBITDA-155.08M-6.16M2,519%
Gain YTD112.208-49.594-226%
P/E Ratio0.20N/A-
Revenue1.4M114M1%
Total Cash187M156M120%
Total Debt107M51.5M208%
TECHNICAL ANALYSIS
Technical Analysis
INBXIPSC
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
82%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OCMGX26.220.70
+2.74%
OCM Gold Investor
REACX26.350.27
+1.04%
American Century Real Estate Inv
UIVPX13.000.11
+0.85%
MFS Intrinsic Value R3
FDEIX28.84N/A
N/A
Fidelity Advisor Capital Development I
FISVX27.34N/A
N/A
Fidelity Small Cap Value Index

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with ACET. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+2.62%
ACET - INBX
40%
Loosely correlated
+0.14%
COGT - INBX
39%
Loosely correlated
+6.55%
IPSC - INBX
38%
Loosely correlated
+4.39%
ZYME - INBX
36%
Loosely correlated
+2.72%
STOK - INBX
35%
Loosely correlated
+5.19%
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
+4.39%
CRSP - IPSC
55%
Loosely correlated
+2.24%
IMNM - IPSC
52%
Loosely correlated
+14.13%
CABA - IPSC
51%
Loosely correlated
+2.16%
FATE - IPSC
50%
Loosely correlated
+3.01%
ARWR - IPSC
48%
Loosely correlated
+3.60%
More